Skip to main content
NIH funding notice PA-18-532

Early-life Factors and Cancer Development Later in Life (R21 - Clinical Trial Not Allowed)

Closed on January 7, 2021.

Posted
December 20, 2017
Close date
January 7, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $489,922 in first-year total cost, median $244,961.

Most frequent study sections

  1. Cancer, Heart, and Sleep Epidemiology A Study Section[CHSA]1
  2. Infectious Diseases, Reproductive Health, Asthma and Pulmonary Conditions Study Section[IRAP]1

Most frequent institutions

  1. DUKE UNIVERSITY1
  2. UNIVERSITY OF CALIFORNIA BERKELEY1
Competing awards under PA-18-532 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Fetal Origins of Testicular Cancer: A Metabolomics Study in Newborns1UH2CA248974-01A1METAYER, CATHERINEPETRICK, LAURENUNIVERSITY OF CALIFORNIA BERKELEY, CA$244,799CHSA
2019Immune Correlates and Mechanisms of Perinatal Cytomegalovirus Infection and Later Life ALL Development1R21CA242439-01WALSH, KYLE MDUKE UNIVERSITY, NC$245,123IRAP

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.